logo

For the Inventor, By the Inventor

Mumbai, India

Christopher M Franco

This inventor holds 6 USPTO granted patents. Top assignee: Hoechst Aktiengesellschaft. Active years: 1988-1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher M Franco. Retrieved from https://idiyas.com/inventor/christopher-m-franco

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 5.9

ph-index = 3

Forward Citations = 34(Granted Patents)


Company Filing History:

goldMedal6 out of 6,705 
 
Hoechst Aktiengesellschaft
 patents

Years Active: 1988-1993

Loading Chart...
6 patents (USPTO):Explore Patents
1. 5271935 - Antibiotic, cammunocin, a process for the preparation thereof, and the (1993-12-21),
2. 5270182 - Antibiotic compounds and their production (1993-12-14),
3. 5162368 - Butalactin and its use as pharmaceutical (1992-11-10),
4. 5114967 - Antibiotic alisamycin and its use (1992-05-19),
5. 4988677 - Macrolide antibiotic and its use as a medicinal agent (1991-01-29),
6. 4738958 - Ansamycin antibiotic and its use as a medicament (1988-04-19),

Title: The Innovative Contributions of Christopher M. Franco

Introduction

Christopher M. Franco, based in Bombay, India, is a prominent inventor known for his significant contributions to the field of antibiotics. With a total of six patents to his name, Franco has made notable advancements in antibiotic compounds and their production, contributing to medical science and pharmacology.

Latest Patents

Franco's most recent patents include an innovative antibiotic known as Cammunocin, which is characterized by a unique process for its preparation. This active substance is derived from the cultivation of Streptomyces species Y-84,36210 (DSM 4329) and exhibits both antibiotic and immunosuppressant activity. Additionally, he has developed novel antibiotic compounds, represented by formulas I and II, that display significant antibiotic activity.

Career Highlights

Franco's career is marked by his tenure at Hoechst Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His work has not only positioned him as a key player in the development of new medical treatments but also underlined his commitment to advancing antibiotic therapies.

Collaborations

Throughout his career, Franco has collaborated with esteemed colleagues such as Bimal N. Ganguli and Sugata Chatterjee. These collaborations have fostered a dynamic environment for innovation, allowing Franco and his associates to share insights and accelerate the development of their groundbreaking research.

Conclusion

Christopher M. Franco remains an influential figure in the world of pharmaceuticals. His expertise in developing antibiotic compounds and his dedication to research have produced impactful innovations that continue to benefit the medical community. As he forges ahead with his work, the implications of his inventions will likely resonate within the industry for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…